Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine

A cancer vaccine comprised of autologous dendritic cells pulsed with synthetic glioma-associated antigen (GAA) peptides with potential antineoplastic activity. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against GAA peptide-expressing glioma cells, resulting in tumor cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:GAA peptide-pulsed autologous dendritic cell vaccine
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search